LEAH MACAULAY: Open Payments
NPI 1184499733 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,668 in 167 payments from 13 companies in 2025. Trend: 2023 $31 · 2024 $1,190 · 2025 $2,668
Food & beverage: $2,668
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $344 |
| Alkermes, Inc. | 19 | $340 |
| Neurocrine BioSciences, Inc. | 17 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $293 |
| Janssen Pharmaceuticals, Inc | 13 | $256 |
| Supernus Pharmaceuticals, Inc. | 16 | $233 |
| Lundbeck LLC | 18 | $222 |
| E.R. Squibb & Sons, L.L.C. | 13 | $220 |
| Vanda Pharmaceuticals Inc. | 14 | $148 |
| Corium, LLC | 5 | $132 |
Products named: ARISTADA, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, Qelbree, COBENFY, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
